GRAIL (NASDAQ:GRAL) Shares Up 7.2% – Time to Buy?

GRAIL, Inc. (NASDAQ:GRAL)’s share price was up 7.2% on Monday . The stock traded as high as $52.77 and last traded at $53.43. Approximately 203,439 shares were traded during trading, a decline of 84% from the average daily volume of 1,271,020 shares. The stock had previously closed at $49.86.

GRAIL Stock Performance

The company has a 50-day simple moving average of $36.33 and a two-hundred day simple moving average of $36.08. The firm has a market capitalization of $2.12 billion, a P/E ratio of -4.48 and a beta of 3.20.

GRAIL (NASDAQ:GRAL) last issued its quarterly earnings results on Tuesday, August 12th. The company reported ($3.18) EPS for the quarter, missing analysts’ consensus estimates of ($3.14) by ($0.04). GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%.The company had revenue of $35.54 million during the quarter, compared to the consensus estimate of $37.57 million. As a group, research analysts forecast that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

Insider Transactions at GRAIL

In other news, CFO Aaron Freidin sold 8,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 15th. The stock was sold at an average price of $38.93, for a total value of $311,440.00. Following the sale, the chief financial officer directly owned 286,020 shares of the company’s stock, valued at $11,134,758.60. The trade was a 2.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, major shareholder Chun R. Ding sold 339,800 shares of the business’s stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $49.53, for a total value of $16,830,294.00. Following the completion of the sale, the insider directly owned 3,305,055 shares in the company, valued at approximately $163,699,374.15. This represents a 9.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 352,002 shares of company stock valued at $17,276,282 in the last ninety days.

Hedge Funds Weigh In On GRAIL

A number of hedge funds have recently added to or reduced their stakes in the company. NWF Advisory Services Inc. purchased a new position in GRAIL in the 2nd quarter worth approximately $1,062,000. Reynders McVeigh Capital Management LLC raised its holdings in GRAIL by 4.7% in the 2nd quarter. Reynders McVeigh Capital Management LLC now owns 108,255 shares of the company’s stock worth $5,566,000 after acquiring an additional 4,892 shares during the last quarter. Osaic Holdings Inc. raised its holdings in GRAIL by 33.7% in the 2nd quarter. Osaic Holdings Inc. now owns 8,880 shares of the company’s stock worth $456,000 after acquiring an additional 2,240 shares during the last quarter. China Universal Asset Management Co. Ltd. raised its holdings in GRAIL by 14.6% in the 2nd quarter. China Universal Asset Management Co. Ltd. now owns 7,725 shares of the company’s stock worth $397,000 after acquiring an additional 985 shares during the last quarter. Finally, Neuberger Berman Group LLC purchased a new position in GRAIL in the 2nd quarter worth approximately $203,000.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.